In recent years, a clear pattern has emerged in paediatric gender medicine: every country that has reviewed the evidence for interventions such as puberty blockers and cross-sex hormones for adolescents has found it to be exceptionally weak, and responded by shifting towards cautious, psychotherapeutic care. In sharp contrast, Nova Scotia has just announced an expansion of its paediatric gender services to ensure that youth across the province can access these controversial medical treatments.